GORE® TIGRIS® Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease
Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies
Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies
Final study results demonstrate for the first time efficacy of long-lasting absorbable biosynthetic mesh in challenging hernia repairs; has potential to end biologics era in hernia repair
Pivotal Multicenter Investigational Study Begins at Medical University of South Carolina (MUSC), Evaluating Safety and Efficacy of Innovative GORE® Carotid Stent
Hybrid of unique bioabsorbable and permanent materials provide a single-stage hernia repair to help minimize complications in preperitoneal applications
Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy
Gore to launch its new hybrid device, GORE® SYNECOR Biomaterial, at the 17th Annual Hernia Repair Conference in Washington, D.C.
Charing Cross International Symposium
Gore designed All-in-One System to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms
Recognition of new technology status will provide additional hospital reimbursement for IBE when used in FDA approved indications
New research methodology will procure real world feedback from surgeons and patients to improve outcomes with GORE® SYNECOR Biomaterial